Skip to ContentSkip to Navigation
How to find us prof. dr. M.J. (Maarten) Postma

Publications

Comparing the impact of high-dose versus standard dose influenza vaccines on hospitalization cost for cardiovascular and respiratory diseases: Economic assessment in the US Veteran population during 5 respiratory seasons using an instrumental variable method

Cost-effectiveness of hepatitis C virus screening, and subsequent monitoring or treatment among pregnant women in the Netherlands

Economic evaluation of orphan drug Lutetium-Octreotate vs. Octreotide long-acting release for patients with an advanced midgut neuroendocrine tumour in the Netherlands

Economic evaluations of chronic obstructive pulmonary disease pharmacotherapy: how well are the real-world issues of medication adherence, comorbidities and adverse drug-reactions addressed?

Efficiency of Diagnostic Testing for Helicobacter pylori Infections: A Systematic Review

Inclusion of Safety-Related Issues in Economic Evaluations for Seasonal Influenza Vaccines: A Systematic Review

Predictors of Health Utility in Relapsing-Remitting and Secondary-Progressive Multiple Sclerosis: Implications for Future Economic Models of Disease-Modifying Therapies

The Tripartite insurance model (TIM): A financial incentive to prevent outbreaks of infections due to multi-drug resistant microorganisms in hospitals

A comparative network meta-analysis of standard of care treatments in treatment-naive chronic hepatitis B patients

A personalised screening strategy for diabetic retinopathy: a cost-effectiveness perspective

Read more

Press/media

Corona aanpak en vaccinaties

Poldercultuur breekt Nederland op bij vaccineren

Gezondheidseconoom RUG: ‘Knullige start vaccinatiecampagne, maar revanche kan nog’

60-plusser met medisch probleem heeft geen 'prikvoorrang' meer, deskundigen verbaasd

Waarom zijn er zulke grote verschillen in de prijzen van coronavaccins?

Steeds minder vaccinaties tegen mazelen

Mensen die coronavaccin nemen, krijgen waarschijnlijk voordelen

Minister De Jonge: 'Bepaalde regels gelden wellicht langer voor mensen zonder vaccinatie'

Kritiek op het Nederlandse vaccinatiebeleid. ‘Het zijn boekhouders’

Het rijksvaccinatieprogramma: wat mag het kosten en wat zijn de opbrengsten?

Read more